SubHero Banner
Text

2nd Quarter 2022

Key topics in this quarter’s edition include:

  • Topical roflumilast for plaque psoriasis 
  • Deucravacitinib for plaque psoriasis
  • Zynteglo (betibeglogene autotemcel) for beta thalassemia 
  • Skysona (elivaldogene autotemcel) for cerebral adrenoleukodystrophy

Download PDF

Text